[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370665-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370665-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","evolutionary-unpredictability-in-cancer-model-systems","Evolutionary Unpredictability in Cancer Model Systems","","Despite advances in molecular prognostic tools, predicting an individual cancer patient’s disease course remains difficult, and the same uncertainty is seen across many experimental cancer model systems. The study combines agent-based mathematical modeling, patient-derived xenograft analyses across cancer types, and in-vitro culture to test how specific conditions alter the stochasticity of cancer clonal landscapes. Results suggest that under these conditions the cancer genome acts as a complex dynamic system with inherently unpredictable long-term evolution, challenging purely random or purely deterministic interpretations of tumor emergence.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/evolutionary-unpredictability-in-cancer-model-systems/370665/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/evolutionary-unpredictability-in-cancer-model-systems/370665.png","ImageObject",300,407,{"name":42,"@type":43},"Putri","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is it still difficult to predict cancer outcomes at the individual level?","Question",{"text":63,"@type":64},"Even with advanced molecular prognostic tools, disease progression is hard to forecast for each patient. The same lack of predictability shows up in many experimental cancer model systems.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What methods does the study use to investigate clonal landscape predictability?",{"text":68,"@type":64},"It uses agent-based mathematical modeling, analyzes patient-derived xenograft model systems across multiple cancer types, and performs in-vitro culture experiments to test how conditions affect stochasticity.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the findings suggest about long-term cancer evolution?",{"text":72,"@type":64},"Under certain conditions, the cancer genome may behave as a complex dynamic system, making its long-term evolution inherently unpredictable.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370665,1792113848,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEvolutionary unpredictability in cancer model systems  \nSubhayan Chattopadhyay1􀀍, Jenny Karlsson1, Michele Ferro1, Adriana Mañas2,3,4, Ryu Kanzaki2, Elina Fredlund5,6,7, Andrew J. Murphy8, Christopher L. Morton8, Natalie Andersson1, Mary A. Woolard8, Karin Hansson2, Katarzyna Radke2, Andrew M. Davidhoff8, Sofie Mohlin5,6,7, Kristian Pietras2, Daniel Bexell2 & David Gisselsson1,9  \nDespite the advent of advanced molecular prognostic tools, it is still difficult to predict the course of disease for cancer patients at the individual level. This lack of predictability is also reflected in many experimental cancer model systems, begging the question of whether certain biological aspects of cancer (eg. growth, evolution etc.) can ever be anticipated or if there remains an inherent unpredictability to cancer, similar to other complex biological systems. We demonstrate by a combination of agent-based mathematical modelling, analysis of patient-derived xenograft model systems from multiple cancer types, and in-vitro culture that certain conditions increase stochasticity of the clonal landscape of cancer growth. Our findings indicate that under those conditions, the cancer genome may behave as a complex dynamic system, making its long-term evolution inherently unpredictable.  \nIn 1993, Donald S. Coffey hypothesized that cancer is an ‘abrupt’ and ‘emergent’ phenomenon caused by the transformation of the cell proliferation machinery from an ordered to a disordered, albeit self-organizing state1. The prevalent somatic mutation theory stating that near-random DNA lesions combined with disease-specific selection cause cancer still indicates a failure to grasp Coffey’s vision of using the self-organizing features of cancer to identify unifying aspects across malignancies2–4. With the advent of precision cancer medicine, major efforts are now being made to characterize the broad spectrum of genetic variation across individual tumors. This has resulted in a fine-tuned associative prognostication of many neoplasms and in identification of treatment targets based on molecular signatures. However, in many cases, the remaining threat of a relapse at an unknown time point, often manifesting as treatment-resistant aggressive disease, reminds us that cancer shares features of resilience with many other self-organizing systems. Cancer’s relapse mechanisms have been thoroughly studied through the lens of genetic diversity, elucidating how tumors evolve along different evolutionary trajectories5 and how resistant clones often appear due to excessive evolutionary branching early in disease, leading to dormant tumor cell populations with a potential to clonally sweep at later stages6,7. Despite the massive amount of data thus accumulated on the molecular routes of relapse, it remains an essentially unpredictable phenomenon. However, as inferred by Coffey decades earlier, cancer is not a purely stochastic phenomenon. Instead, it results from runaway tissue homeostasis, transitioning into a complex, dynamic, and adaptive system. This notion begs the question whether we can use generic knowledge from other complex systems to better understand tumorigenesis.  \nThe generalized logistic model (with the Gompertz curve being a special case) is a commonly used construct for simulating spatially constricted (bounded) growth of species/cell populations, and it is often used to emulate solid tumor growth8–10. Several comparative studies analyzing in-vivo tumor growth have established the suitability of logistic functions in tumor growth estimation10, 11. Additionally, logistic functions have been used to illustrate clonal selection and genetic drift in solid tumors in silico12. Simulations have shown that the evolutionary trajectories of cancers are highly dependent on how cell populations grow and how they interact  \n1Division of Clinical Genetics, Department of Laboratory Medicine, Lund ","cbCaipQlo9rReG61","https://ap.wps.com/l/cbCaipQlo9rReG61","pdf",2117360,"English","# Evolutionary unpredictability in cancer model systems\n## Introduction\n## Results","[{\"question\":\"Why is it still difficult to predict cancer outcomes at the individual level?\",\"answer\":\"Even with advanced molecular prognostic tools, disease progression is hard to forecast for each patient. The same lack of predictability shows up in many experimental cancer model systems.\"},{\"question\":\"What methods does the study use to investigate clonal landscape predictability?\",\"answer\":\"It uses agent-based mathematical modeling, analyzes patient-derived xenograft model systems across multiple cancer types, and performs in-vitro culture experiments to test how conditions affect stochasticity.\"},{\"question\":\"What do the findings suggest about long-term cancer evolution?\",\"answer\":\"Under certain conditions, the cancer genome may behave as a complex dynamic system, making its long-term evolution inherently unpredictable.\"}]","Evolutionary Unpredictability in Cancer Model Systems | PDF",1790189691,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9dd61d6095ccb9a084b4baaf10c9419d.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60c585a0a573e76b1ee8dceacdea427f.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65f81b14d81b6172361e844734edaaad.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17d95b29e2dca6ac1bc81767f3c2f949.webp",980,1287]